Kellerhals Carrard advised Rhenopharma Group in this acquisition. Rhenopharma Group, a leading service provider in the pharmaceutical sector headquartered in Basel, acquired Konapharma AG, a contract...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard acted as legal advisor to the investors and Kontivia Beteiligungen AG on this transaction. Baker McKenzie advised the sellers on all legal aspects of...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard advised Aitonomi in intensified strategic partnership by JOST. JOST Werke SE, one of the world’s leading manufacturers and suppliers of safety-relevant systems for the...
You must be a Standard 1 Year member to access this content.
CMS advised Bruker while Kellerhals Carrard advised Chemspeed Technologies AG on this transaction. Bruker Corporation, a Nasdaq-listed company specialized in high-value analytical and diagnostic solutions at...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard acted as legal advisor to the buyer. Orell Füssli Group acquired a majority stake in hep Verlag and becomes the largest private Swiss publisher of...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard advised Ameliora Wealth Management. Ameliora Wealth Management announced the acquisition of the Swiss offshore business with American private clients of UBP Investment Advisors. The...
You must be a Standard 1 Year member to access this content.
Advestra advised the sellers. Kellerhals Carrard advised the investors and Kontivia AG on this transaction. Adrian Schmassmann, CEO and long-time majority shareholder of Katadyn Group, together...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard, working alongside Walkers, instructed by onshore law firm Gibson, Dunn & Crutcher LLP, advised MoonLake Immunotherapeutics AG on this transaction. Pestalozzi advised Helix Acquisition...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard acted as legal advisor to STILLE in this transaction. Stille AB, a medical device company whose shares are listed on the Nasdaq First North...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard acted as lead legal advisor to MoonLake Immunotherapeutics AG on this transaction. Walder Wyss has advised Merck KGaA on the deal. MoonLake Immunotherapeutics AG,...
You must be a Standard 1 Year member to access this content.
